Related Experiment Video
Updated: Jun 9, 2026
07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Learning from oncocytic tumors: Why choose inefficient mitochondria?
Giuseppe Gasparre1, Giovanni Romeo, Michela Rugolo
1Dip. Scienze Ginecologiche, Ostetriche e Pediatriche-U.O. Genetica Medica, Pol. Universitario S.Orsola-Malpighi, Università di Bologna, 40138, Bologna, Italy. giusgas@yahoo.it
Biochimica Et Biophysica Acta
|August 25, 2010
Summary
Mitochondrial genes and metabolism are key in oncocytic cancer development. Studying these oncocytic tumors reveals insights into mitochondrial roles in cancer progression and bioenergetics.
Area of Science:
- Oncology
- Cell Biology
- Mitochondrial Biology
Background:
- Oncocytic transformation involves significant changes in cancer cells.
- Mitochondria play a crucial role in cellular metabolism and energy production.
- Mitochondrial dysfunction is increasingly recognized in various cancers.
Purpose of the Study:
- To review the role of mitochondrial genes and metabolism in oncocytic transformation.
- To discuss the history and bioenergetic implications of mitochondrial derangement in oncocytic tumors.
- To explore how oncocytic tumors can inform general conclusions about mitochondria in cancer.
Main Methods:
- Literature review of oncocytic tumors and mitochondrial function.
- Analysis of ultrastructural and genetic alterations in mitochondria.
- Discussion of bioenergetic pathways and metabolic reprogramming.
Main Results:
- Oncocytic tumors exhibit distinct mitochondrial ultrastructure alterations.
- Disruptions in respiratory complexes and mutations in mitochondrial genes are common.
- These features highlight the critical role of mitochondrial metabolism in cancer development.
Conclusions:
- Mitochondrial genes and metabolism are central to oncocytic cancer.
- Oncocytic tumors serve as a model to understand broader mitochondrial involvement in cancer.
- Further research into mitochondrial derangement offers therapeutic opportunities.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...